Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ann Surg Oncol. 2010 May;17(5):1219-25. doi: 10.1245/s10434-010-0976-5. Epub 2010 Apr 20.
Hepatocellular carcinoma remains a leading cause of cancer death worldwide. There are an increasing number of patients that do not meet traditional criteria for surgical resection as a result of historically poor outcomes. We define these oncologically high-risk patients as those with either one of these risk factors or a combination of them: large (>5 cm) primary tumors, multinodular disease, and/or major vascular invasion. With appropriate selection and preparation, long-term survival is possible in this subset of patients after resection. This review focuses on the surgical treatment of these high-risk patients, focusing on our own institution's approach and methods as well as reviewing the literature pertinent to the support of our current practice.
肝细胞癌仍然是全球癌症死亡的主要原因。由于历史上预后较差,越来越多的患者不符合传统的手术切除标准。我们将这些具有以下任何一个或多个危险因素的肿瘤生物学高风险患者定义为:大(>5cm)原发性肿瘤、多结节性疾病和/或主要血管侵犯。经过适当的选择和准备,这部分患者在手术后可以获得长期生存。这篇综述重点讨论了这些高危患者的手术治疗,重点介绍了我们机构的方法和方法,并回顾了支持我们当前实践的相关文献。